Reuters [10 April, 2017]
“At the tipping point for eliminating the African sleeping sickness in the DRC”
African Business [23 February, 2017]
“Partnerships to fight disease”
[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.
Forum des As [31 January, 2017]
“Connue communément sous le nom de la maladie” – “Commonly known as the disease”
October 4-6, 2017
Graeme Bilbe, R&D Director, DNDi and Suman Rijal, Director of DNDi Regional Office India took part in the event.
Action on Antibiotic Resistance (ReAct) Africa Annual Conference 2017
September 18-19, 2017
DNDi Africa’s Director, Monique Wasunna, gave a presentation on DNDi‘s various programme models.
September 11-15, 2017
Florent Mbo, HAT Platform Coordinator, DNDi presented a poster at the Conference.
Ärzte Zeitung [30 January, 2017]
“London Declaration entfaltet ihre Wirkung” – “London Declaration develops its impact”
Research Research [26 January, 2017]
July 9-14, 2017
São Paulo, Brazil
Charles Mowbray, Head of Discovery, DNDi presented on drug discovery for neglected diseases.
The Huffington Post [17 January, 2017]
“This man went abroad and brought back a disease U.S. doctors had never seen”
April 19-22, 2017
Bernard Pécoul, Executive Director, and Wilfried Mutombo HAT Project Coordinator at DNDi, spoke at the event.
April 2-5, 2017
Charles Mowbray, Head of Drug Discovery at DNDi presented on catalyzing R&D for neglected diseases.
KEMRI Annual Scientific and Health Conference
February 8-10, 2017
Gina Ouattara, Project Coordinator for HIV/HCV, and Kevin Onyango, Project Coordinator for Mycetoma, both from the DNDi Africa office, presented at the event.
Our staff, partners, and stakeholders share their highlights from 2016.